Karuna Three-For-Three As Another KarXT Schizophrenia Trial Hits Primary Endpoint

 
• By Alaric DeArment
  
Karuna announced results of a third positive study of KarXT in schizophrenia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D